These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 19783776

  • 1. Role of nitric oxide as a key mediator on cardiovascular actions of atrial natriuretic peptide in spontaneously hypertensive rats.
    Costa MA, Elesgaray R, Caniffi C, Fellet A, Mac Laughlin M, Arranz C.
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H778-86. PubMed ID: 19783776
    [Abstract] [Full Text] [Related]

  • 2. Renal actions of atrial natriuretic peptide in spontaneously hypertensive rats: the role of nitric oxide as a key mediator.
    Elesgaray R, Caniffi C, Savignano L, Romero M, Mac Laughlin M, Arranz C, Costa MA.
    Am J Physiol Renal Physiol; 2012 Jun 01; 302(11):F1385-94. PubMed ID: 22378819
    [Abstract] [Full Text] [Related]

  • 3. C-type natriuretic peptide effects on cardiovascular nitric oxide system in spontaneously hypertensive rats.
    Caniffi C, Elesgaray R, Gironacci M, Arranz C, Costa MA.
    Peptides; 2010 Jul 01; 31(7):1309-18. PubMed ID: 20363270
    [Abstract] [Full Text] [Related]

  • 4. Role of NPR-C natriuretic receptor in nitric oxide system activation induced by atrial natriuretic peptide.
    Costa MA, Elesgaray R, Balaszczuk AM, Arranz C.
    Regul Pept; 2006 Jul 15; 135(1-2):63-8. PubMed ID: 16712979
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sex differences in the beneficial cardiac effects of chronic treatment with atrial natriuretic Peptide in spontaneously hypertensive rats.
    Romero M, Caniffi C, Bouchet G, Elesgaray R, Laughlin MM, Tomat A, Arranz C, Costa MA.
    PLoS One; 2013 Jul 15; 8(8):e71992. PubMed ID: 23951276
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats.
    Costa MA, Lopez Verrilli MA, Gomez KA, Nakagawa P, Peña C, Arranz C, Gironacci MM.
    Am J Physiol Heart Circ Physiol; 2010 Oct 15; 299(4):H1205-11. PubMed ID: 20675563
    [Abstract] [Full Text] [Related]

  • 9. Role of cardiovascular nitric oxide system in C-type natriuretic peptide effects.
    Costa MA, Elesgaray R, Caniffi C, Fellet A, Arranz C.
    Biochem Biophys Res Commun; 2007 Jul 20; 359(1):180-6. PubMed ID: 17532295
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impaired Cardiovascular Function in Male Rats with Hypo- and Hyperthyroidism: Involvement of Imbalanced Nitric Oxide Synthase Levels.
    Yousefzadeh N, Jeddi S, Ghasemi A.
    Endocr Metab Immune Disord Drug Targets; 2021 Jul 20; 21(3):526-533. PubMed ID: 32384042
    [Abstract] [Full Text] [Related]

  • 12. Polyphenol-containing azuki bean (Vigna angularis) extract attenuates blood pressure elevation and modulates nitric oxide synthase and caveolin-1 expressions in rats with hypertension.
    Mukai Y, Sato S.
    Nutr Metab Cardiovasc Dis; 2009 Sep 20; 19(7):491-7. PubMed ID: 19157815
    [Abstract] [Full Text] [Related]

  • 13. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats.
    Vaziri ND, Ni Z, Oveisi F.
    Hypertension; 1998 Jun 20; 31(6):1248-54. PubMed ID: 9622137
    [Abstract] [Full Text] [Related]

  • 14. Alterations of nitric oxide synthase expression with aging and hypertension in rats.
    Chou TC, Yen MH, Li CY, Ding YA.
    Hypertension; 1998 Feb 20; 31(2):643-8. PubMed ID: 9461235
    [Abstract] [Full Text] [Related]

  • 15. Atrial natriuretic peptide influence on nitric oxide system in kidney and heart.
    de los Angeles Costa M, Elesgaray R, Loria A, Balaszczuk AM, Arranz C.
    Regul Pept; 2004 May 15; 118(3):151-7. PubMed ID: 15003831
    [Abstract] [Full Text] [Related]

  • 16. Altered regulation of renal nitric oxide and atrial natriuretic peptide systems in angiotensin II-induced hypertension.
    Bae EH, Ma SK, Lee J, Kim SW.
    Regul Pept; 2011 Oct 10; 170(1-3):31-7. PubMed ID: 21616096
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-acting calcium channel blocker, azelnidipine, increases endothelial nitric oxide synthase in the brain and inhibits sympathetic nerve activity.
    Kimura Y, Hirooka Y, Sagara Y, Sunagawa K.
    Clin Exp Hypertens; 2007 Jan 10; 29(1):13-21. PubMed ID: 17190727
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.